0 (1y: -100%)

Market Cap	175.82 M	P/E(ttm)
Enterprise Value	141.51 M	P/B	7.81

SHP- NYSE (USA)
ShangPharma Corp

Not Rated

Top Ranked Predictable Companies

$0.00

1 Severe Warning Sign 2 Medium Warning Signs 1 Good Sign

Bookmark

Summary
Guru Trades
10-Y Financials
Analysis
DCF
Financial Charts
Insider
Articles
Compare
Votes
Definitions

ShangPharma Corp Other Long Term Assets: 1.5 ( as of Sep12)

* All numbers are in millions except for per share data SHP 10-Y Financials »

Annual Data Quarterly Data

Financial Dictionary

Accounts Payable
Accounts Receivable
Altman Z-Score
Asset Turnover
Beneish M-Score
Book Value per Share
Buyback Ratio
Capital Surplus
Cash and cash equivalents
Cash and cash equivalents
Cash Flow for Capital Expenditures
Cash Flow for Dividends
Cash Flow from Discontinued Operations
Cash Flow from Financing
Cash Flow from Investing
Cash Flow from Operations
Cash Flow from Others
Cash to Debt
Common Stock
Cost of Goods Sold
Credit Losses Provision
Current Portion of Long-Term Debt
Days Inventory
Days Payable
Days Sales Outstanding
Debt to Equity (%)
Deferred Policy Acquisition Costs
Depreciation, Depletion and Amortization
Dividend Growth Rate
Dividend Payout Ratio
Dividend Yield
Dividends Per Share
E10
Earnings Before Depreciation and Amortization
Earnings per Share
Earnings Yield
Earnings Yield (Joel Greenblatt)
EBITDA per Share
Enterprise Value
Equity Investments
Equity to Asset
EV/EBIT
EV/EBITDA
EV/Revenue
Fees and Other Income
Financial Strength
Fixed Maturity Investment
Forward Rate of Return
Free Cash Flow
Free Cashflow per Share
Future Policy Benefits
GAVA
Graham Number
Gross Margin
Gross Profit
Intangible Assets
Interest Coverage
Interest Expense
Intrinsic Value (DCF Projected)
Intrinsic Value (DCF)
Intrinsic Value (DE)
Inventory
Inventory Turnover
Long-Term Debt
Market Cap
Median P/S Value
Money Market Investments
Net Cash
Net Cash (per share)
Net Change in Cash
Net Current Asset Value
Net Current Asset Value (per share)
Net Income
Net Interest Income
Net Investment Income
Net Issuance of Debt
Net Issuance of Stock
Net Loan
Net Margin
Non Interest Income
Non-Recurring Items
Operating Income
Operating Margin
Other Current Assets
Other Current Liabilities
Other Expenses
Other liabilities
Other Long Term Assets
Other Long-Term Liabilities
P/B Ratio
P/E Ratio
P/E Ratio(ttm)
P/S Ratio
Paid-In Capital
PEG
Peter Lynch Fair Value
Piotroski F-Score
Policy Acquisition Expense
Policyholder Benefits & Claims
Policyholder Funds
Pre-Tax Income
Preferred Stock
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
Profitability Rank
Property, Plant and Equipment
Research & Development
Retained Earnings
Return on Assets
Return on Capital
Return on Capital - Joel Greenblatt
Return on Equity
Revenue
Revenue per Share
Securities & Investments
Selling, General, & Admin. Expense
Shiller P/E Ratio
Short Ratio
Short-term investments
Tangible Book Value per Share
Tax Expense
Total Assets
Total Current Assets
Total Current Liabilities
Total Deposits
Total Equity
Total Liabilities
Total Premiums Earned
Total Shares Outstanding
Unearned Premiums
Unpaid Loss & Loss Reserve
Yield on Cost

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

ShangPharma Corp Other Long Term Assets: 1.5 ( as of Sep12)

Financial Dictionary